Valuation: AddLife AB

Market Cap 19.45B 1.99B 1.72B 1.63B 1.48B 2.77B 191B 2.79B 7.48B 96.78B 7.47B 7.31B 309B P/E 2026 *
36.4x
P/E 2027 * 28.4x
Enterprise Value 23.15B 2.37B 2.05B 1.94B 1.76B 3.3B 227B 3.32B 8.91B 115B 8.9B 8.7B 367B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.94x
Free-Float
90.8%
Yield 2026 *
1.05%
Yield 2027 * 1.3%
6 months+98.36%
Current year+98.36%
Current year 15.75
Extreme 15.75
15.75
1 year 15.75
Extreme 15.75
15.75
3 years 15.75
Extreme 15.75
15.75
5 years 7.94
Extreme 7.94
42
10 years 7.94
Extreme 7.94
42
Manager TitleAgeSince
Chief Executive Officer 54 01/01/2022
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 59 05/03/2015
Director/Board Member 57 01/01/2015
Director/Board Member 62 01/01/2015
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.99B
+0.75%-2.35%-22.60%+1.74% 177B
+0.46%+2.13%-0.36%+13.34% 120B
-0.60%-0.91%+10.47%+78.95% 61.69B
-0.11%+3.21%-0.34%-29.86% 50.64B
+0.27%-3.53%+3.35%+39.11% 48.16B
+2.15%+4.94%+14.98%-7.63% 32.62B
+1.56%-5.08% - - 28.17B
-0.51%+7.79%+40.58%-7.96% 25.69B
+0.07%-1.06%-10.97%+3.77% 21.33B
Average +0.43%-1.21%+4.39%+11.43% 62.75B
Weighted average by Cap. +0.49%-1.25%-3.63%+12.63%

Financials

2026 *2027 *
Net sales 10.9B 1.11B 966M 913M 827M 1.55B 107B 1.56B 4.19B 54.22B 4.19B 4.09B 173B 11.64B 1.19B 1.03B 976M 883M 1.66B 114B 1.67B 4.48B 57.94B 4.47B 4.38B 185B
Net income 534M 54.64M 47.33M 44.76M 40.52M 76.05M 5.24B 76.62M 205M 2.66B 205M 201M 8.48B 685M 70.05M 60.68M 57.38M 51.94M 97.49M 6.72B 98.22M 263M 3.41B 263M 257M 10.87B
Net Debt 3.7B 379M 328M 310M 281M 527M 36.31B 531M 1.42B 18.41B 1.42B 1.39B 58.71B 3.09B 316M 274M 259M 234M 440M 30.32B 443M 1.19B 15.37B 1.19B 1.16B 49.03B
Logo AddLife AB
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Employees
2,360
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
159.60SEK
Average target price
200.00SEK
Spread / Average Target
+25.31%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!